JMDNA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
JMDNA - overview
Established
2011
Location
Shanghai, Shanghai, China
Primary Industry
Biotechnology
About
Established in 2011 and based in Shanghai, China, JMDNA is a biomedical technology company that focuses on development of DNA diagnosis program and application of clinic service, containing noninvasive genetic testing for women and children, molecular diagnosis of liver disease, molecular diagnosis of tumors and so on. It also supply susceptibility gene testing program and service of physical examination for public though the website.
Current Investors
Ping An Trust, Hiway Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment, Medical Software
Website
www.jmdna.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
JMDNA - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.